Ascendis Pharma A/S (ASND.OQ)
ASND.OQ on NASDAQ Stock Exchange Global Select Market
61.00USD
3:59pm EST
61.00USD
3:59pm EST
Change (% chg)
$0.75 (+1.24%)
$0.75 (+1.24%)
Prev Close
$60.25
$60.25
Open
$61.09
$61.09
Day's High
$62.10
$62.10
Day's Low
$60.92
$60.92
Volume
10,550
10,550
Avg. Vol
32,478
32,478
52-wk High
$76.98
$76.98
52-wk Low
$34.40
$34.40
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.02 | -0.547 |
| Mar '18 | 0.03 | -1.069 | |
| FY 2017 | Dec '17 | 0.28 | -0.925 |
| Sep '17 | 0.43 | -1.039 | |
| Jun '17 | 0.44 | -0.945 | |
| Mar '17 | 0.37 | -0.775 | |
| FY 2016 | Dec '16 | 1.04 | -0.535 |
| Sep '16 | 1.17 | -0.724 | |
| Jun '16 | 1.14 | -0.528 | |
| Mar '16 | 1.26 | -0.817 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 6 | 0.26 | 1.14 | 0.00 | 0.77 |
| Quarter Ending Mar-19 | 1 | 0.00 | 0.00 | 0.00 | 0.40 |
| Year Ending Dec-18 | 7 | 1.20 | 5.00 | 0.00 | 2.57 |
| Year Ending Dec-19 | 6 | 1.78 | 10.00 | 0.00 | 2.17 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 6 | -1.09 | -0.59 | -1.30 | -0.68 |
| Quarter Ending Mar-19 | 1 | -0.97 | -0.97 | -0.97 | -- |
| Year Ending Dec-18 | 8 | -3.79 | -2.94 | -4.29 | -2.71 |
| Year Ending Dec-19 | 7 | -4.13 | -1.35 | -5.29 | -3.20 |
Sales and Profit Figures in Euro (EUR);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 81.01 | 29.57 | |
| P/E High - Last 5 Yrs. | -- | 267.91 | 46.44 | |
| P/E Low - Last 5 Yrs. | -- | 85.11 | 24.51 | |
| Beta | 0.82 | 0.74 | 0.88 | |
| Price to Sales (TTM) | 2,957.15 | 232.78 | 15.43 | |
| Price to Book (MRQ) | 6.76 | 16.33 | 4.06 | |
| Price to Tangible Book (MRQ) | 6.84 | 20.88 | 13.80 | |
| Price to Cash Flow (TTM) | -- | 48.95 | 21.23 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.40 | 1.64 | |
| Dividend Yield - 5 Year Avg | -- | 0.22 | 1.45 | |
| Dividend 5 Year Growth Rate | -- | 3.72 | -5.78 | |
| Payout Ratio(TTM) | -- | 7.81 | 41.88 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -95.95 | 148.87 | 7.10 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -74.90 | 63.88 | 5.63 | |
| Sales - 5 Yr. Growth Rate | -37.14 | 22.16 | 7.39 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 42.12 | 46.11 | 36.31 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -20.15 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 20.32 | 7.73 | |
| Capital Spending - 5 Yr. Growth Rate | 26.46 | 34.35 | 8.00 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 3.36 | 2.55 |
| Current Ratio (MRQ) | 9.87 | 6.59 | 3.51 |
| LT Debt to Equity (MRQ) | 0.00 | 18.51 | 11.13 |
| Total Debt to Equity (MRQ) | 0.00 | 23.97 | 14.84 |
| Interest Coverage (TTM) | -40.40 | -205.37 | 40.28 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 32.29 | 54.38 | |
| Gross Margin - 5 Yr. Avg. | -- | 47.38 | 52.96 | |
| EBITD Margin (TTM) | -18,835.26 | -- | -- | |
| EBITD - 5 Yr. Avg | -473.06 | -162.73 | 15.85 | |
| Operating Margin (TTM) | -18,938.16 | -1,819.18 | -16.28 | |
| Operating Margin - 5 Yr. Avg. | -478.97 | -175.96 | 11.08 | |
| Pre-Tax Margin (TTM) | -17,478.42 | -1,749.43 | -14.67 | |
| Pre-Tax Margin - 5 Yr. Avg. | -477.57 | -178.84 | 11.39 | |
| Net Profit Margin (TTM) | -17,395.26 | -1,744.55 | -18.01 | |
| Net Profit Margin - 5 Yr. Avg. | -474.67 | -178.80 | 7.65 | |
| Effective Tax Rate (TTM) | -- | 14.32 | 21.32 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.97 | 24.45 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 6,223 | 24,520,427 | 722,980,797 | |
| Net Income/Employee (TTM) | -1,082,437 | -3,918,019 | 83,628,555 | |
| Receivable Turnover (TTM) | 3.25 | 8.33 | 5.19 | |
| Inventory Turnover (TTM) | -- | 2.80 | 4.12 | |
| Asset Turnover (TTM) | 0.00 | 0.47 | 0.85 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -51.72 | -0.91 | 10.15 | |
| Return on Assets - 5 Yr. Avg. | -43.95 | 2.43 | 10.82 | |
| Return on Investment (TTM) | -57.64 | -0.53 | 12.77 | |
| Return on Investment - 5 Yr. Avg. | -52.07 | 2.24 | 13.88 | |
| Return on Equity (TTM) | -57.64 | -3.22 | 14.47 | |
| Return on Equity - 5 Yr. Avg. | -52.07 | -1.62 | 15.19 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -66.78 | -52.17 | -37.14 |
| EPS (TTM) % | -42.88 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Ascendis Pharma A/S
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 5.92 | 5.39 | 99 | 92 |
| 13 Week | -6.24 | -4.48 | 99 | 95 |
| 26 Week | -3.24 | -5.09 | 99 | 94 |
| 52 Week | 79.19 | 66.54 | 99 | 98 |
| YTD | 58.21 | 52.10 | 99 | 93 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 97.08% |
| # of Holders: | 118 |
| Total Shares Held: | 40,620,094 |
| 3 Mo. Net Change: | 876,491 |
| # New Positions: | 5 |
| # Closed Positions: | 7 |
| # Increased Positions: | 22 |
| # Reduced Positions: | 15 |
| # Net Buyers: | 7 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.